Renovacor Announces Partnerships with the Dilated Cardiomyopathy Foundation
PHILADELPHIA--(BUSINESS WIRE)-- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies...
Search for Articles
Feb 28, 2022
Feb 9, 2022
HAYA Therapeutics Establishes U.S. Location
LAUSANNE, Switzerland & SAN DIEGO--(BUSINESS WIRE)--HAYA Therapeutics, SA, a company developing precision medicines that target...
Feb 4, 2022
CroíValve Raises an €8M Series A Round to Support a Feasibility Clinical Study Expands the Board of Directors and Leadership Team
Dublin, Ireland, 4 February 2022 – CroíValve, a Dublin based medical device company developing a...
Jan 24, 2022
Puzzle Medical Devices Inc. announces the closing of its major Seed financing round to support its first-in-human study
MONTREAL, January 24, 2022 /PRNewswire/ – Montreal based Puzzle Medical Devices Inc., a medical device...
Dec 9, 2021
Aeromics and Simcere Announce the First-In-Human Dosing of Chinese Healthy Volunteers in Simcere’s Phase I Study of The SIM0307 (AER-271), A New Drug for Brain Edema
NEW HAVEN, Conn. and NANJING, China, Dec. 9, 2021 /PRNewswire/ -- Simcere Pharmaceutical Group and Aeromics,...
Nov 15, 2021
Renovacor Announces Third Quarter 2021 Financial Results and Provides Corporate Update
PHILADELPHIA--(BUSINESS WIRE)-- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies...